CS Medica Feed

Land	Danmark
Lista	Spotlight DK
Sektor	Hälsovård
Industri	Läkemedel & Handel

2024-04-04 14:01:13 CS MEDICA A/S Breaks Through Asian Market Barrier with Approval of Protective Nasal Gel in Malaysia -7,93% | 0,02 MDKK

2024-04-03 16:48:51 CS MEDICA A/S: CS MEDICA Update: Rescheduled Q4 2023 Presentation -8,77% | 0,14 MDKK

2024-04-02 16:01:44 Correction:CS MEDICA A/S: Publication of 2023 Q report -1,94% | 0,02 MDKK

2024-03-29 08:00:00 CS MEDICA A/S: Release of 2023 Q report, for the period October - December 2023, including an invitation to a live-streamed conference call on 5st April, at 11 AM CET. -1,94% | 0,02 MDKK

2024-02-29 16:36:08 CS MEDICA A/S: Minutes of the General Assembly -9,72% | 0,13 MDKK

2024-02-28 15:40:09 CS MEDICA A/S: Letter from the CEO: CS MEDICA's 2024 Progress Report +9,64% | 0,03 MDKK

2024-02-20 08:02:10 CS MEDICA A/S Partners with New Distributor to Launch CANNASEN® into Jordan +4,38% | 0,02 MDKK

2024-02-14 18:52:52 CS MEDICA A/S: Notice of Shareholders' Annual General Meeting -8,27% | 0,10 MDKK

2024-02-14 18:49:12 CS MEDICA A/S: Publication of Annual Report 2022/2023 -8,27% | 0,10 MDKK

2024-02-02 14:38:14 CS MEDICA A/S Achieves New Milestone with Patent on their Wound Care Treatment. +11,37% | 0,13 MDKK

2024-01-26 15:23:14 CS MEDICA A/S: CS MEDICA Breaks New Ground in Australia with Registration of CANNASEN® Pain Patch and Launch of its Cosmetic Products. +9,09% | 0,04 MDKK

2024-01-23 16:00:09 CS MEDICA A/S: Danske Bank Extends CS MEDICA's Credit Line +2,40% | 0,23 MDKK

2023-12-27 13:32:59 CS MEDICA A/S Announces FDA authorization for commercialization for Eight Products in the U.S. Market +63,22% | 0,43 MDKK

2023-12-14 08:30:00 CS MEDICA A/S presents the CEO Letter of December 2023 +4,64% | 0,03 MDKK

2023-11-29 11:52:06 CS MEDICA A/S: CS MEDICA postpones its Annual Report to February 24, 2024 and the Annual General Meeting to February 29, 2024 -4,76% | 0,01 MDKK

2023-11-22 16:42:47 CS MEDICA A/S: Release of 2022/2023 Q4 report, for the period July - September 2023, including an invitation to a live-streamed conference call on 5st December, at 11 AM CET. -6,93% | 0,00 MDKK

2023-11-17 17:17:29 CS MEDICA A/S: CS MEDICA defers the Q4 2022/2023 quarterly report until Wednesday 22. November 2023 -15,38% | 0,01 MDKK

2023-10-31 11:45:18 CS MEDICA A/S Achieves Milestone with Patent on Nasal Protect Gel -11,53% | 0,13 MDKK

2023-10-26 17:49:13 CS MEDICA A/S: CS MEDICA: CANNASEN® is now a registered brand in Australia +8,91% | 0,04 MDKK

2023-10-12 14:00:32 CS MEDICA A/S: CS MEDICA Announces Indian State's FDA Approval for Two Cosmetic Products +2,08% | 0,07 MDKK

2023-10-10 15:23:04 CS MEDICA A/S: Danske Bank Backs CS MEDICA with DKK 1,2 Million Credit Line -2,68% | 0,06 MDKK

2023-10-09 08:00:00 CS MEDICA A/S: CS MEDICA Named Finalist in the 2023 European Lifestars Awards for Post-IPO Raise of the Year -3,37% | 0,01 MDKK

2023-09-06 08:30:00 CS MEDICA A/S: CS MEDICA's Joint Venture with RongShi Successfully Represented at CPHI & PMEC China 2023 -1,91% | 0,04 MDKK

2023-08-30 12:13:37 CS MEDICA A/S Achieves Milestone with Patent on Nasal Night Spray +10,38% | 0,18 MDKK

2023-07-18 08:00:00 CS MEDICA A/S: Release of 2022/2023 Q3 report, for the period April - June 2023, including an invitation to a live-streamed conference call on 8nd August, at 10 AM CET. -21,82% | 0,32 MDKK

2023-07-14 13:58:50 CS MEDICA A/S: CS MEDICA announces that CANNORDIC India Pvt. Ltd. is Established to Expand Presence in India -1,39% | 0,02 MDKK

2023-06-30 15:51:53 CS MEDICA A/S: Statement of Extraordinary General Meeting -0,68% | 0,02 MDKK

2023-06-21 13:32:30 CS MEDICA A/S Signs New Own-Label Agreement on Pain Patch +0,98% | 0,03 MDKK

2023-06-16 14:37:32 CS MEDICA A/S Secures Trademark Approval in Canada -4,28% | 0,13 MDKK

2023-06-15 13:26:35 CS MEDICA A/S Secures Future Compliance with New Medical Device Regulation through Signed Contract with Notify Body +4,81% | 0,06 MDKK

2023-06-14 17:13:31 CS MEDICA A/S: Notice of Extraordinary General Meeting -0,95% | 0,02 MDKK

2023-05-26 11:28:10 CS MEDICA A/S: CS MEDICA Onboards distributors with first-year orders of DKK 5.6M and cash flow positively effect by shorter lead times +5,28% | 0,20 MDKK

2023-05-17 08:00:00 CS MEDICA A/S: Publication of Q2 2022/2023 report & invitation to live-streamed conference on May 24, at 10 AM CET +1,47% | 0,14 MDKK

2023-05-15 10:53:41 CS MEDICA A/S's CANNASEN® Pain Patch receives approval from Israel's Ministry of Health and is set to debut as the first-ever OTC product with CBD in Israel. +0,29% | 0,14 MDKK

2023-05-09 14:30:39 CS MEDICA A/S exhibits at the leading event Vitafoods Europe with suppliers and experts from over 100 countries today +5,19% | 0,15 MDKK

2023-05-08 12:14:17 CS MEDICA A/S: CS MEDICA Announces Positive Results from Clinical Trial of Nasal Protect Gel for Hay Fever/Allergic Rhinitis. +2,67% | 0,14 MDKK

2023-04-27 14:00:30 CS MEDICA A/S: CS MEDICA Joint Venture, RongShi MEDICA (Ordos) Co. Ltd., update +4,78% | 0,04 MDKK

2023-04-14 19:47:21 CS MEDICA A/S: CS MEDICA Greenlights Establishment of CANNORDIC India Pvt. Ltd. as Part of Global Expansion Strategy -2,27% | 0,09 MDKK

2023-04-14 16:21:14 CS MEDICA A/S: Statement of Extraordinary General Meeting +2,02% | 0,40 MDKK

2023-04-14 13:46:03 CS MEDICA A/S Announces "Proof of Concept" with Successful Clinical Trial Results of CANNASEN® Pain Patch +2,02% | 0,40 MDKK

2023-03-30 17:52:21 CS MEDICA A/S: Medical Device Company Approved to Prolong MDR Transition Until 31. December 2028 +3,30% | 0,13 MDKK

2023-03-30 10:18:48 CS MEDICA A/S: Notice of Extraordinary General Meeting -1,48% | 0,11 MDKK

2023-03-26 19:09:46 CS MEDICA A/S: CS MEDICA has entered a joint venture regarding production of CS-MEDICA's CANNASEN® CBD medical products in China and distribution of CANNASEN® CBD products to the Asian market. +51,57% | 2,12 MDKK

2023-03-26 19:08:51 CS MEDICA A/S: CS MEDICA has entered into agreement with investor regarding directed share issue of DKK 60M at DKK 28.13 per share. +51,57% | 2,12 MDKK

2023-03-01 17:12:17 Correction: CS MEDICA A/S: CEO, Lone Henriksen, CFO Gitte Lund Henriksen and COO Heidi Ahlefeldt-Laurvig buys shares in the Company -1,54% | 0,25 MDKK

2023-03-01 16:32:38 CS MEDICA A/S: CEO, Lone Henriksen, CFO Gitte Lund Henriksen and COO Heidi Ahlefeldt-Laurvig buys shares in the Company -1,54% | 0,25 MDKK

2023-02-17 09:19:59 CS MEDICA A/S: Release of 2022/2023 Q1 report, for the period October - December 2022, including an invitation to a live-streamed conference call on 22nd February, at 10 AM CET. 0,00% | 0,33 MDKK

2023-02-14 17:52:15 CS MEDICA A/S: Minutes of the General Assembly +4,08% | 0,05 MDKK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

2025-02-14	Bokslutskommuniké 2024
2024-11-14	Kvartalsrapport 2024-Q3
2024-08-16	Kvartalsrapport 2024-Q2
2024-05-30	Årsstämma 2024
2024-05-17	Kvartalsrapport 2024-Q1
2024-03-01	Ordinarie utdelning CSMED 0.00 DKK
2024-02-14	Bokslutskommuniké 2023
2023-12-15	Ordinarie utdelning CSMED 0.00 DKK
2023-07-18	Kvartalsrapport 2023-Q3
2023-05-17	Kvartalsrapport 2023-Q2
2023-04-14	Extra Bolagsstämma 2023
2023-02-17	Kvartalsrapport 2023-Q1
2023-02-14	Årsstämma 2023
2023-02-10	Ordinarie utdelning CSMED 0.00 DKK
2022-11-18	Bokslutskommuniké 2022
2022-08-13	Kvartalsrapport 2022-Q3
2022-05-20	Kvartalsrapport 2022-Q2
2022-02-18	Kvartalsrapport 2022-Q1
2021-12-10	Ordinarie utdelning CSMED 0.00 DKK
2021-12-09	Årsstämma 2022
2021-11-18	Bokslutskommuniké 2021

CS Medica

Kalender

Beskrivning

CS Medica

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden